Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results

BACKGROUND: The use of stereotactic body radiotherapy (SBRT) as the primary treatment modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was to analyze the long-term results of PCa patients treated with SBRT. METHODS: This non-selected, real-life patient cohort...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Radiat Oncol
Glavni autori: Vuolukka, Kristiina, Auvinen, Päivi, Tiainen, Erno, Palmgren, Jan-Erik, Heikkilä, Janne, Seppälä, Jan, Aaltomaa, Sirpa, Kataja, Vesa
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7362647/
https://ncbi.nlm.nih.gov/pubmed/32664981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01608-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items